[Form 4] Myseum, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Darin Myman, Chief Executive Officer and Director of Myseum, Inc., reported purchases of common stock on 09/19/2025. The Form 4 shows three purchase transactions: 300 shares at $2.145, 1,000 shares at $2.15 and 2,700 shares at $2.1695, totaling 4,000 shares acquired the same day. Following those transactions the report lists beneficial ownership rising from 190,816 to 194,516 shares.
The filing also reports an indirect interest noted "By spouse" and includes a standard disclaimer that the reporting person disclaims beneficial ownership of the securities listed. The form is signed and dated 09/19/2025.
Positive
- Insider purchases: CEO/Director acquired a total of 4,000 shares on 09/19/2025 at prices between $2.145 and $2.1695.
- Increased reported ownership: Beneficial ownership rose to 194,516 shares after the transactions.
Negative
- Disclaimer of beneficial ownership: The reporting person disclaims beneficial ownership of the securities listed, which may limit interpretability of the purchases.
- Indirect ownership noted: The filing lists an indirect interest "By spouse," adding complexity to ownership attribution.
Insights
TL;DR: CEO/Director executed three open-market purchases totaling 4,000 shares on 09/19/2025, modestly increasing reported holdings.
The transactions are straightforward non-derivative purchases executed at prices between $2.145 and $2.1695. Reported beneficial ownership increased to 194,516 shares. For investors, insider purchases can signal confidence, but magnitude should be weighed against total outstanding shares and recent trading patterns which are not provided in this filing.
TL;DR: Filing documents routine insider purchases and an indirect interest via spouse, with a standard disclaimer of beneficial ownership.
The Form 4 properly discloses the reporting person's roles as CEO and Director and the specific purchase lots and prices. The notation of indirect ownership by a spouse and the disclaimer warrant attention for clarity on ultimate control, but the form includes the required signature and dates, meeting disclosure formalities.